Phase I study of the mutant IDH1 inhibitor ivosidenib: Long-term safety and clinical activity in patients with conventional chondrosarcoma Meeting Abstract
| Authors: | Tap, William D.; Cote, Gregory Michael; Burris, Howard A.; Gore, Lia; Beeram, Muralidhar; Conley, Anthony Paul; Gianolio, Diego A.; Qu, Zhe; Gliser, Camelia; Pandya, Shuchi Sumant; Trent, Jonathan C. |
| Abstract Title: | Phase I study of the mutant IDH1 inhibitor ivosidenib: Long-term safety and clinical activity in patients with conventional chondrosarcoma |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.11532 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting abstract: 11532 -- Meeting also presented virtually -- Source: Cinahl |
